Moloney Securities Asset Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Moloney Securities Asset Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-539	Closed	-$6K	–	426
2022 Q3	$6K	Hold	539	–	–	﹤0.01%	371
2022 Q2	$9K	Hold	539	–	–	﹤0.01%	362
2022 Q1	$14K	Sell	539 -113	-17%	-$2.38K	﹤0.01%	399
2021 Q4	$14K	Buy	+652	New	+$22K	﹤0.01%	435
2019 Q2	–	Sell	-250	Closed	-$31K	–	339
2019 Q1	$31K	Buy	250 +23	+10%	+$3.14K	0.01%	299
2018 Q4	$32K	Buy	227 +122	+116%	+$30.7K	0.01%	277
2018 Q3	$32K	Buy	105 +37	+54%	+$11.4K	0.01%	296
2018 Q2	$21K	Buy	+68	New	+$23.8K	0.01%	294

Other funds holding ONCS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Moloney Securities Asset Management's ONCS Position: Q4 2022 in Review

Moloney Securities Asset Management sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 539 shares — an estimated $6K sold.

Moloney Securities Asset Management first reported a position in ONCS in Q2 2018 and held it in 8 quarters. The position peaked at $32K in Q4 2018. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

Moloney Securities Asset Management reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
Moloney Securities Asset Management sold 539 OncoSec Medical Incorporated shares in Q4 2022, an estimated $6K.
Moloney Securities Asset Management first reported a position in OncoSec Medical Incorporated in Q2 2018 and held it in 8 quarters.
Moloney Securities Asset Management's OncoSec Medical Incorporated position peaked at $32K in Q4 2018.
17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Moloney Securities Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.